GlassScriptPhysician profile
Blair Haws Tull
NPI 1972859320
$1,224.92
in general payments reported to CMS, 2019-2025
28 companies · $120 in 2025
The $120 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $379 · 2020: $178 · 2021: $170 · 2022: $140 · 2023: $114 · 2024: $123 · 2025: $120.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $358.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $357.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $331.29 | 2019-2022 | |
| Roche Diagnostics Corporation | $122.08 | 2019-2021 | |
| Pfizer INC. | $85.29 | 2019-2025 | |
| Daiichi Sankyo INC. | $79.10 | 2021-2025 | Injectafer |
| Hologic Sales and Service, LLC | $69.10 | 2019-2024 | Acessa Provu System, Novasure, Coolseal Generator |
| Coopersurgical, INC. | $60.83 | 2024 | Paragard T 380a |
| Amag Pharmaceuticals, INC. | $47.36 | 2019-2020 | |
| Mayne Pharma Commercial LLC | $42.41 | 2022 | |
| Ferring Pharmaceuticals INC. | $33.56 | 2019 | |
| Minerva Surgical, INC | $31.96 | 2025 | |
| Allergan, INC. | $26.99 | 2019 | |
| Axonics, INC. | $26.95 | 2021-2022 | |
| Conmed Corporation | $22.49 | 2023 | Airseal |
| Organon LLC | $21.23 | 2021-2024 | |
| Lupin INC. | $19.49 | 2020 |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $19.22 | 2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $18.57 | 2019 | |
| Olympus America INC. | $18.29 | 2020 | |
| Becton, Dickinson and Company | $17.83 | 2023 | Bd Onclarity |
| Therapeuticsmd, INC. | $17.03 | 2022 | |
| Shield Therapeutics INC | $15.98 | 2023 | Accrufer |
| Medtronic Vascular, INC. | $15.64 | 2019 | |
| Aspira Women'S Health INC | $15.08 | 2024 | Ova1 |
| Boston Scientific Corporation | $14.88 | 2019 | |
| Davol INC. | $14.70 | 2022 | |
| Agile Therapeutics, INC. | $12.83 | 2023 | Twirla |
| Medtronic, INC. | $12.59 | 2022 | |
| Merck Sharp & Dohme LLC | $12.15 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Blair Tull listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.